T29 (Carbamazepine extended-release 400 mg)
Pill imprint T29 has been identified as Carbamazepine extended-release 400 mg.
Carbamazepine is used in the treatment of trigeminal neuralgia; bipolar disorder; schizoaffective disorder; epilepsy; borderline personality disorder (and more), and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 400 mg is not a controlled substance under the Controlled Substance Act (CSA).
- 400 mg
- Prescription only
- Drug Class:
- Dibenzazepine anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Taro Pharmaceutical Industries Ltd.
- National Drug Code (NDC):
- Inactive Ingredients:
- corn starch
sodium starch glycolate type A potato
Note: Inactive ingredients may vary.
|NDC Code||Manufacturer / Repackager|
|54868-6074||Physicians Total Care Inc (repackager)|
|60429-0938||Golden State Medical Supply (repackager)|
More about carbamazepine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 220 Reviews – Add your own review/rating
- Carbamazepine chewable tablets
- Carbamazepine suspension
- Carbamazepine sustained-release capsules
- Carbamazepine sustained-release tablets
- More... (2)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.